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Abstract: The objective of this study was to determine the effect of a Melissa officinalis and Passiflora caerulea 
infusion on the severity of physiological chronic stress induced by movement restriction in CF-1 mice. 40 CF-1 male 
mice, six weeks of age, were divided into 4 groups (n = 10 for each group): (1) Group RS/MP received two treat-
ments, induced stress through movement restriction and a infusion of Melissa officinalis and Passiflora caerulea in 
a dose of 200 mg/kg, (2) RS group with induced stress using movement restriction, (3) MP group, which received 
only a infusion, and (4) a CONTROL group that received no treatment. The severity of the stress was obtained by 
analysis of the physical parameters of body weight, thymus and spleen, and associated biomarkers with stress, 
corticosterone, and glucose. Animals that consumed Melissa officinalis and Passiflora caerulea infusion had lower 
plasma corticosterone levels (Student’s t test, Welch, p = 0.05), which is the most important biomarker associated 
with physiological stress, demonstrating a phytotherapy effect.
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Introduction
Stress is a physiological reaction of the organ-
ism in order to affront threatening or demand-
ing situations [1] and involves appropriate 
responses to promote survival, altering the 
physiological and behavioral processes. The 
main component of the endocrine stress 
response involves activation of the hypotha-
lamic-pituitary-adrenocortical (HPA), which trig-
gers a neuroendocrine cascade which culmi-
nates with the synthesis and secretion of 
glucocorticoids (mainly cortisol in humans and 
corticosterone in rats, mice and other species) 
[2]. When physiological stress becomes chron-
ic, it turns an adaptive response to a health 
problem, given that many systems are adverse-
ly affected by the prolonged exposure to gluco-
corticoids and catecholamines, causing memo-
ry problems, poor concentration, mood 
disturbances and immune system level chang-
es [3, 4].
The model used to study the physiological 
stress in experimental animals is movement 
restriction [5], which is a method to be used in 
different intervals of time and is susceptible to 
modification in order to prevent a habituation to 
the stressor stimulus [6]. In rodents, physiologi-
cal stress chronicity could be reviewed by 
weight logs, measurements of serum corticos-
terone levels and glucose, among others [7].
Currently there are various therapies of tradi-
tional and complementary medicine, which 
seek to reduce the effects of chronic stress. 
Melissa officinalis, is one of the plants with 
attributed soothing properties, such as anxio-
lytic, antispasmodic and stress decrease, and 
is used in different medications and is popular-
ly used on infusions [8, 10]. Passiflora caerulea 
is another herb that is used for therapeutic pur-
poses; mainly because it traditionally shows 
sedative, antispasmodic and anxiolytic proper-
ties. It is also used to sleep induction, when 
insomnia as a neurogenic reason [11]. Herbs as 
Melissa officinalis and Passiflora caerulea have 
no contraindications and are popularly used to 
ease the ravages of stress [8, 12].
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There is evidence that Melissa officinalis, 
through its ethanolic extract, (200 mg/kg) has 
the ability to increase cell proliferation, differ-
entiation and integration of neuroblasts in 
granular cells, because it reduces serum levels 
of corticosterone and as well it increases gam-
ma-aminobutyric acid (GABA) levels in the hip-
pocampal dentate gyrus in male mice C57BL/6J 
[13]. In humans, Melissa officinalis is expended 
in 300 mg capsules. It improves cognitive per-
formance, better mood and reduces acutely 
induced anxiety [3]; also in randomized con-
trolled trials, when it was administered in cap-
sules of 300 and 600 mg. it was shown to 
reduce the effects of acute stress and associ-
ated itself with Valeriana officinalis, in a com-
puterized simulator acute stress [8, 9]. There is 
no evidence linking Melissa officinalis with 
chronic stress.
In the Passiflora genus, it could be presented in 
capsules of 500 mg. Passiflora incarnata 
reduces anxiety in patients when is adminis-
tered previously to an ambulatory surgery [14]. 
Passiflora caerulea has been isolated and 
identified unequivocally; chrysin, a monofla-
voide present in this plant, administered intra-
cerebroventricularly to mice prevents the 
expression of tonic-clonic seizures induced by 
pentylenetetrazol, supporting the hypothesis 
that chrysin acts via central benzodiazepine 
receptors, but to the date it has not been pos-
sible to isolate or identify these natural mole-
cules [11, 15]. It has been compared the effect 
of chrysin, extracted from Passiflora caerulea, 
with the drug diazepam concluding that chrysin 
induces anxiolytic effects without sedation and 
muscle relaxation [16]. There are no reports on 
the effects of stress in Passiflora caerulea.
Despite the evidence, there is no information 
that these herbal separate or together, pre-
pared as an infusion, have medicinal effects on 
physical and physiological markers associated 
with chronic stress, which is why an infusion of 
Melissa officinalis and Passiflora caerulea will 
be administered experimentally on animals 
subjected to chronic stress induced by restrict-
ed movement.
Materials and methods
To conduct this research it was used a random-
ized experimental design. The explanatory vari-
able was the exposure to an infusion of Melissa 
officinalis and Passiflora caerulea; the 
response variable was the severity of chronic 
stress. All procedures were approved according 
to the Committee on Bioethics of the University 
of Talca (folio 00170). The protocols followed 
the guidelines of the Guide for the Care and 
Use of Laboratory Animals (U.S. National 
Research Council, 1996).
Animals
40 CF-1 male mice were used, six weeks of age 
(± 22 g), no consanguineous, with their corre-
sponding health certification, obtained from 
the Public Health Institute of Chile, which were 
kept under controlled conditions of tempera-
ture (22 ± 1 °C) and cycles of 12 hours (light-
dark , beginning at 08:00 am), with freely avail-
Figure 1. Distribution of the experimental units. Each group was divided into two cages of five mice and two shelves 
(one upper and one lower) in the same rack, on the maintenance room.
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able food and water, in groups of 5 mice, kept 
in polycarbonate cages enriched with tissue 
paper and PVC pipes ranging his orientation 
each week [17], in the animal facility of the 
University of Talca, Chile. The mice were ran-
domly divided into 4 groups (Figure 1): (1) RS/
MP group (n = 10) received two treatments, 
stress movement restriction and infusion of 
Melissa officinalis and Passiflora caerulea, (2) 
RS group (n = 10) stress by movement restric-
tion, (3) MP group (n = 10) received only the 
infusion, and (4) CONTROL group (n = 10) no 
treatment received. The mice weight and food 
consumption was recorded 2 times a week.
Procedures
Aqueous extract of Melissa officinalis and 
Passiflora caerulea (MP): 100 ml were daily 
prepared as a infusion from commercial stan-
dardized capsules of MELIPASS® (KNOP 
Laboratorios Ltda., Santiago, Chile), which con-
tained the dried plant material (127.5 mg of 
c/u). The aqueous extract was obtained in the 
Institute of Chemical and Natural Resources, 
University of Talca, Chile, according to the previ-
ously described process [10]. Briefly, by mac-
eration of 631.4 mg of MELIPASS® in 100 ml of 
hot distilled water (100 °C for 10 minutes), the 
suspension was filtered through filtered paper 
which resulted in 200 mg of MP in 100 ml water 
according to the effec-
tive dose of Melissa offi-
cinalis previously 
described [13]. The mice 
in groups MP and MP/RS 
received the infusion 
freely with drinking bot-
tles orally. During these 
days of the investigation, 
both groups only drank 
the prepared infusion.
Induction of stress (RS): 
From the first day of the 
pilot phase the animals 
were stressed out for 
five hours a day for 32 
days, on properly venti-
lated acrylic cylinders 
(25 mm diameter), which 
were covered by dim-
ming boxes. Each ses-
sion was conducted 
between 12:30 am and 
17:30 pm, in which time the mice had no access 
to food or water. To avoid habituation to the 
stressor stimulus, we designed a protocol that 
involved two additional procedures, Fragance/
Ledge 1: between 9 and 23 days, during the 
period of restriction of animal were stood in 
their shelves, but day by half were exposed to 
different flavors (banana, oregano, lemon balm, 
black pepper, coriander, mint, cinnamon, basil, 
cloves, dill). Fragance/Ledge 2: between days 
24 and 32 animals were placed in different 
shelves, receiving daily change scent (Figure 
2). Once the stress cycle was finished, the ani-
mals returned to the maintenance room, were 
the unstressed groups were located.
Laboratory assays: Prior to sample collection, 
the animals were weighted and then anesthe-
tized with ketamine/xylazine/acepromazine 
(Drag Pharma Invetec Chile SA, Santiago, Chile) 
in a ratio of 50/5/1 mg/kg intramuscularly (IM). 
Proven anesthesia, after the last cycle of 
stress, plasma samples were obtained by a car-
diac puncture. Then, it was performed the 
euthanasia of animals by cervical dislocation. 
Samples were centrifuged and stored at -20 °C 
until the determination of plasma corticoste-
rone levels (nmol/L) and glucose (mg/dL) in the 
Laboratory of Animal Physiology and 
Endocrinology, University of Concepción, 
Chillán, Chile. Corticosterone was quantified 
Figure 2. Key aspects of the experimental phase. It shows the distribution of 
animals according to received treatment and interventions.
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using a commercial ELISA kit (DRG International, 
Austin, TX, USA) validated for mouse corticoste-
rone, with intra-assay coefficient of variation of 
2.1%. Glucose was determined using a kit 
(Roche, Mannheim, Germany) based on the 
method GOD-POD (glucose oxidase and peroxi-
dase) and measured at 505 nm using a spec-
trophotometer (Thermo Electron Co., Vantaa, 
Finland) with a interassay variation coefficient 
of 0.5-1.3% and intra-assay of 0 to 2.7%.
Tissue preparation: Immediately on euthana-
sia, thymus and spleen were removed and 
stored in 10% formalin with a pH of 7.4, and 
then were weighed on an analytical balance 
(AAA/LE, Adam Equipment, Danbury, USA). We 
calculated the ratio of each of these bodies 
according to the body weight of the animals.
Severity of stress: The severity of stress was 
measured by analyzing physical parameters 
(body weight, thymus and spleen) and biomark-
ers associated with stress (serum corticoste-
rone and glucose).
Statistical analysis: Results are presented as 
mean + - standard deviation. They were tested 
for normality (Kolmogorov-Smirnov) and homo-
geneity of variance (Levene test). Quantitative 
data were compared in pairs, using the Student 
t test, (Welch). It was also used the one-way 
ANOVA test, adjusted for multiple comparisons 
(Bonferroni and Tukey). For statistical analysis, 
we used a 95% confidence level. To perform the 
statistical analysis was used the software 
SPSS® Statistics 17 and graphics were made 
with Microsoft® Office Excel®.
Results
The restriction of movement decreases body 
weight gain (g) of CF-1 mice
Measurements were made with food consump-
tion and weight of the mice twice a week (Figure 
3). Food consumption and body weight tended 
to increase throughout the experimental phase. 
The data was analyzed by one-way ANOVA with 
repeated measures, with an adjustment for 
multiple comparisons (Bonferroni), showing no 
significant difference for food consumption; the 
opposite situation was found for body weight 
between the CONTROL group versus RS and 
MP/RS (p = 0.05).
Movement restriction decreases the spleen 
weight (g) of CF-1 mice: Decreased weight of 
spleen and thymus are considered as adaptive 
effects in response to stress. The thymus 
weight (g) and spleen (g) can be seen in Table 
1. The body weight and the lymphoid weights 
were distributed according to normal parame-
ters; it was calculated with the relationship (thy-
mus or spleen weight/body weight) for each 
mouse. Differences for thymus weights were 
not considered statistically significant using 
ANOVA and post-hoc Tukey. The same test was 
used to compare the weights of the spleen and 
it was found statistically significant differences 
for RS and CONTROL groups (p = 0.01), and for 
the group RS/MP and CONTROL (p = 0.001), 
being the CONTROL group the one with most 
weight.
The CF-1 mice treated Melissa officinalis and 
Passiflora caerulea had lower corticosterone 
Figure 3. The restriction of movement decreases body weight gain. It could be appreciated irregular increase in food 
consumption (A) and the continuous increase in body weight in the study groups (B), which was statistically differ-
ent when comparing the CONTROL group and the groups RS and RS/MP (p=0.05, one-way ANOVA with repeated 
measures and when it was adjusted for multiple comparisons by Bonferroni).
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levels: Corticosterone is the most important 
biomarker associated with stress. 
Corticosterone levels (ng/mL) and glucose 
(mg/dL) are shown in Table 2. The Student t 
test, Welch, established significant differences 
between the groups treated with Melissa offici-
nalis and Passiflora caerulea (MP and MP/RS); 
with the group receiving movement restriction 
(RS) for the measurement of corticosterone (p 
= 0.05). RS and CONTROL groups showed sig-
nificant differences (p = 0.01). Interestingly, 
among the CONTROL, MP and MP/RS groups 
there was no statistically significant difference 
(p > 0.16).
Mice receiving Passiflora caerulea and Melissa 
officinalis with movement restriction (MP/RS) 
had higher levels of circulating glucose. 
Statistical analysis were performed using 
Student’s t test, Welch, establishing that there 
were significant differences between CONTROL 
and RS when compared with MP/RS (p = 0.05).
Discussion
To determine the induction of chronic stress for 
restricting movement throughout the experi-
mental period it was recorded twice weekly, 
body weight and food consumption, and after 
the experimental phase, serum levels of corti-
costerone and glucose were measured and cal-
culated the weight of spleen and thymus in 
relation to the body weight of all animals.
In the conducted stress model was considered 
a time of 5 hours per day [6], during which the 
animals were kept under a box of light attenua-
tion, as during the dark phase is when they 
have the most activity; therefore immobilized 
during this period generates a higher stress [7]. 
To avoid additional stress on the environment it 
was enriched for all animals of all groups [17].
In this study, as well as in the literature, it was 
considered that the influence that could lead to 
the habituation on animals subjected to chron-
ic stress, since exposure to a repetitively stimu-
lus produces a less intense physiologic [18, 
19], for which a protocol was designed to avoid 
this problem, introduced from the second week 
a change in the smell of the microenvironment 
where the movement restriction going on and 
as of the last week began to change common 
position on the shelves of the procedure room 
who had until then mice. These changes during 
the experimental were able to adapt the model 
for animals.
The weight loss is considered as an adaptive 
effect in animals under stress [20]. In this study 
all animals tend to gain weight over time, con-
sidering the growth period in which they find 
themselves. However, mice subjected to move-
ment restrictions have lower body weights, sta-
tistically significant differences between the 
CONTROL group versus RS and MP/RS, related 
with other studies that have found a direct rela-
tionship of weight loss stress [21]. This differ-
ence in the weight may be due to transient 
hypophagia while animals have restrictors, and 
are in registered feed consumption without any 
significant differences between groups; there-
fore, the change in body mass probably is due 
to endogenous factors altered by the restriction 
of movement.
Corticosterone is the most important biomark-
er associated with stress, studies examining 
chronic stress support this associating this to 
movement restriction [19, 22, 23]. By analyzing 
this biomarker, it was found that the animals 
treated with movement restriction present 
higher circulating levels of corticosterone. 
Between RS and CONTROL groups are signifi-
Table 1. Relative weight (g) of thymus and 
spleen (thymus or spleen weight/body weight; 
means ± DE)
Thymus Spleen
g x 10-4 g x 10-4
CONTROL 16.1 ± 6.6 51.7 ± 11.1
MP 18.5 ± 5.6 43.2 ± 10.2
RS 23.6 ± 20.6 35.3 ± 11.1**,a
MP/RS 34 ± 5.5 14.7 ± 4.2**,a
MP Melissa officinalis y Passiflora caerulea, RS move-
ment restriction. Tukey contrast, significativally difference 
*p ≤ 0.05, **p ≤ 0.01. aWith CONTROL.
Table 2. Plasmatic levels of corticosterone 
and glucose (means ± DE) measured after 
stress cycles 
Corticosterone Levels Glucose Levels
ng/mL mmol/L
CONTROL 356.9 ± 59.9**,a 222,3 ± 38.5*,b
MP 345 ± 60.1**,a 217.0 ± 29.3
RS 418 ± 25.5*,b 200.3 ± 46.7*,b
MP/RS 373.4 ± 54.3 264.9 ± 52.7
MP Melissa officinalis y Passiflora caerulea, RS move-
ment restriction. t - test Student-Welch, significativally 
difference *p ≤ 0.05, **p ≤ 0.01. aWith RS. bWith MP/RS.
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cant differences, determining that they did 
reflect the induction of stress in the RS group. It 
should be noted that there are significant differ-
ences between the groups treated with Melissa 
officinalis and Passiflora caerulea (MP and MP/
RS), with the group receiving movement restric-
tion (RS) for the measurement of corticoste-
rone. It is also interesting to mark that between 
CONTROL, MP and MP/RS there is no statisti-
cally significant difference. This evidence sup-
ports our hypothesis; mice that consumed 
Melissa officinalis and Passiflora caerulea had 
lower plasma corticosterone levels, and so it 
may be assumed, in our design, that mice pre-
sented no chronic stress.
One consequence of the release of glucocorti-
coids as a result of activation of the stress cas-
cade is the elevation of blood glucose, stress-
activated sympathetic nerve fibers of the 
autonomic nervous system, which innervate 
the tissues of the immune system, the release 
of catecholamines from the nerve cells result-
ing in hormonal secretion of norepinephrine 
and epinephrine from the adrenal medulla 
cells. Catecholamines released during stress 
conditions contribute to the development of 
hyperglycemia by direct stimulation of glucose 
output [20] which interferes with glucose dis-
posal tissues as glucocorticoids inhibit insulin 
release [24]. Therefore we analyzed the levels 
of circulating glucose (mg/dL). Blood samples 
were taken after completion of the last cycle of 
stress established, there were significant dif-
ferences between CONTROL and RS when com-
pared with MP/RS (p = 0.05); paradoxically we 
found lower values of glucose in the RS group. 
These data differs from those reported previ-
ously, where are said that physiological mark-
ers are statistically significant in all groups of 
stress [20]. However, this drop in glucose can 
be caused by chronic stress and it causes 
decrease in body weight, and thus may induce 
lower blood glucose levels [24]. The MP group 
tends to have fewer circulating glucose than 
the CONTROL group, which is consistent with 
corticosterone levels found, reinforcing the 
idea of the protective role that could give the 
aqueous extract of Melissa officinalis and 
Passiflora caerulea in the body.
The involution of the thymus and spleen, are 
also seen as bioadaptative effects in animals 
under stress [20]. To investigate the relevance 
of in the central nervous system (CNS) and the 
endocrine system involves reciprocal interac-
tions with the immune system. There are two 
primary mechanisms involved in the mediation 
of stress on the immune functions: adrenergic 
innervation of the lymphoid organs and produc-
tion of a hormonal hyper secretion of HPA [20, 
23, 25].
It was investigated the role of endogenous glu-
cocorticoids in the involution of the thymus 
after stress inducing movement restriction 
[23]. Stress restriction, measured by increased 
glucocorticoid endogenous mice, resulted in 
rapid degradation of the genome of thymocytes 
and ultimately apoptosis of these cells, causing 
a diminution in the subpopulation of CD4+ and 
CD8 thymocytes, while that decreases thymus 
weight. Overall results indicate that the chang-
es induced in the thymus during stress con-
straint probably were due to a specific process 
of cell death induced by glucocorticoids, and 
the possible migration of viable cells from the 
thymus into the circulation to other lymphoid 
organs.
It was concluded that various stressors are 
able adrenal hypertrophy, increasing the 
amount of glucocorticoids in mice [25], while it 
causes atrophy of thymus and decrease thymo-
cytes. It also notes that the amount of plasma 
glucocorticoids was inversely proportional to 
the weight of the spleen and the number of B 
lymphocytes, which when adrenalectomy is 
performed in stressed mice, no changes were 
generated in the spleen and thymus. Moreover, 
the changes associated with the frequency of 
stress, began to be observed after 4 days of 
severe stress; otherwise observed changes 
were reversible once the stress conditions 
ceased, and system plasticity restore their nor-
mal functions.
In our research, the weight of the thymus and 
spleen were related to body weight of the mice 
and the weight of the thymus or spleen/body 
weight. Observing these values of thymus 
weight, differences were not statistically signifi-
cant, probably, as explained Hori et al., that it 
requires a longer exposure to the stressor stim-
ulus in order to show a morphological change in 
the atrophy of this organ, or may be due to the 
removal of the thymus, which is difficult and the 
sample was not harmless, which could alter the 
records. Measurement of spleen concords with 
previous evidence; statistically significant dif-
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ferences between groups RS and MP/RS, when 
compared with the CONTROL group (< 0.05), 
both with less weight than the CONTROL.
The results for physical and plasma biomark-
ers, in this research, support the chronic stress 
induced by movement restriction and taken 
actions to prevent habituation. Moreover, pro-
cedures have shown that an aqueous extract of 
Melissa officinalis and Passiflora caerulea 
reduces plasma corticosterone, the most 
important biomarker associated with stress, 
with no effects described above for the combi-
nation of these phytotherapeutic. Stress can 
cause several problems physiological and psy-
chological; our results point to an alternative 
herbal medicine in order to combat and solve 
the disorders caused by chronic stress. Future 
research is still needed to verify the results, 
involving clinical trials with patients.
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